HAEM5:Volunteer Assignments and Opportunities
Jump to navigation
Jump to search
Welcome!
A new version of the Heme/Lymphoid book (5th edition) is in beta form on the WHO website with publication of a final form anticipated in 2024; we're aligning the related CCGA content to the new structure.
- For assignments, please see the "Author" column below (highlighted blue).
- If empty (no name is present), please volunteer to create content for that disease!
- If "PENDING" is present, the original author of that disease page is currently being contacted about revising the content.
- To volunteer, please [Contact us] with your page of interest.
- Note - "NEW (No Prior)" in the 4th edition columns means either the disease is a new entity in the 5th edition or the disease was present in the 4th edition without content previously added.
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clonal haematopoiesis | Disease | Meenakshi Mehrotra | 4/8/24 | Pending | Fabiola Quintero-Rivera (FQR) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Clonal cytopenias of undetermined significance | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Chronic myeloid leukaemia | Disease | PENDING | FQR | Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive | Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | Complete | Date page was created | |||||||
| Chronic neutrophilic leukaemia | Disease | PENDING | FQR | Chronic Neutrophilic Leukemia (CNL) | Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine **contributed equally | Complete | Date page was created | |||||||
| Chronic eosinophilic leukaemia | Disease | PENDING | FQR | Chronic Eosinophilic Leukemia, Not Otherwise Specified | Chelsea D. Kramish; Daynna J.Wolff | complete/pending faculty review | ||||||||
| Polycythaemia vera | Disease | PENDING | FQR | Polycythemia Vera (PV) | Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center | Complete | ||||||||
| Essential thrombocythaemia | Disease | PENDING | FQR | Essential Thrombocythemia (ET) | Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN | Complete | ||||||||
| Primary myelofibrosis | Disease | PENDING | FQR | Primary Myelofibrosis (PMF) | T. Niroshi Senaratne, UCLA | Complete | 8/4/2020 before submission |
|||||||
| Juvenile myelomonocytic leukaemia | Disease | PENDING | FQR | Juvenile Myelomonocytic Leukemia (JMML) | Sarah Rapisardo, PhD, FACMG | Assistant Professor, Pathology
Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories |
PENDING importing content and reference formatting | FQR has emailed SR several times, last 4/20/22 | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Myeloproliferative neoplasm, NOS | Disease | PENDING | FQR | Myeloproliferative Neoplasm (MPN), Unclassifiable | Thomas Lee, MD, PhD, University of California, Los Angeles | Complete | ||||||||
| Cutaneous mastocytosis | Disease | PENDING | FQR | Cutaneous Mastocytosis | S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD | Complete | ||||||||
| Systemic mastocytosis | Disease | PENDING | FQR | Systemic Mastocytosis | Abdullah Osme, MD, University Hospitals Cleveland Medical Center, Case Western Reserve University Shashi Shetty, Ph.D. FACMG, FCCMG, University Hospitals Cleveland Medical Center, Case Western Reserve University | Complete | ||||||||
| Mast cell sarcoma | Disease | PENDING | FQR | Mast Cell Sarcoma | Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL | Complete | ||||||||
| Myelodysplastic neoplasm with low blasts and 5q deletion | Disease | PENDING | FQR | Myelodysplastic Syndrome (MDS) with Isolated del(5q) | Xiaolin Hu, Ph.D; Teresa Smolarek, Ph.D, FACMG | Complete | ||||||||
| Myelodysplastic neoplasm with low blasts and SF3B1 mutation | Disease | PENDING | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||||
| Myelodysplastic neoplasm with biallelic TP53 inactivation | Disease | Eric McGinnis (assigned to new 5th edition page - FQR is this reviewed?) | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||||
| Myelodysplastic neoplasm with low blasts | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Myelodysplastic neoplasm, hypoplastic | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Myelodysplastic neoplasm with increased blasts | Disease | PENDING | FQR | Myelodysplastic Syndrome (MDS) with Excess Blasts | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | Complete | ||||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Childhood myelodysplastic neoplasm with low blasts | Disease | PENDING | FQR | Refractory Cytopenia of Childhood | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | Complete | ||||||||
| Childhood myelodysplastic neoplasm with increased blasts | Disease | PENDING | FQR | Refractory Cytopenia of Childhood | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | Complete | ||||||||
| Chronic myelomonocytic leukaemia | Disease | PENDING | FQR | Chronic Myelomonocytic Leukemia (CMML) | Linsheng Zhang, MD, PhD | Complete | ||||||||
| Myelodysplastic/myeloproliferative neoplasm with neutrophilia | Disease | PENDING | FQR | Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative | Linsheng Zhang, MD, PhD | Complete | ||||||||
| Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis | Disease | PENDING | FQR | Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) | Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine | Complete | Date page was created | |||||||
| Myelodysplastic/myeloproliferative neoplasm, NOS | Disease | PENDING | FQR | Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable | Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia | Complete | ||||||||
| Acute promyelocytic leukaemia with PML::RARA fusion | Disease | (Rabail Aslam, MD)
Shashi Shetty, Ph.D. |
7/1/24 | Jennelle Hodge (JH)/ Malini Sathanoori (MS) | Acute Promyelocytic Leukemia (APL) with PML-RARA | Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D. | Complete | 03/01/2021-MS (re-review) | ||||||
| Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion | Disease | Mayuri Shende (trainee) and Scott Turner (mentor) |
9/22/24 | Pending | JH_MS | Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 | Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA |
Complete | 04/26/2021-MS (re-review) | |||||
| Acute myeloid leukaemia with CBFB::MYH11 fusion | Disease | Mayuri Shende (trainee) and Scott Turner (mentor) |
9/22/24 | Pending | JH_MS | Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA |
Complete | 03/01/2021-MS (re-review) | |||||
| Acute myeloid leukaemia with DEK::NUP214 fusion | Disease | PENDING | JH_MS | Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 | Jennelle C. Hodge, PhD, FACMG | Complete | 02/24/2021-MS (re-review) | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Acute myeloid leukaemia with RBM15::MRTFA fusion | Disease | PENDING | JH_MS | Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 | Jennelle C. Hodge, PhD, FACMG | Complete | ||||||||
| Acute myeloid leukaemia with BCR::ABL1 fusion | Disease | JH_MS | Acute Myeloid Leukemia (AML) with BCR-ABL1 | Kay Weng Choy MBBS, Monash Medical Centre | Complete | |||||||||
| Acute myeloid leukaemia with KMT2A rearrangement | Disease | (Rabail Aslam, MD)
Shashi Shetty, Ph.D. |
7/1/24 | JH_MS | Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 | Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D. | Complete | 03/01/2021-MS (re-review) | ||||||
| Acute myeloid leukaemia with MECOM rearrangement | Disease | PENDING | JH_MS | Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM | Gordana Raca MD PhD, University of Southern California, Los Angeles | Complete | Need permission for figure? Update WHO? | |||||||
| Acute myeloid leukaemia with NUP98 rearrangement | Disease | Eric McGinnis, MD, Fatma Al-Bulushi (trannee) | 12/20/23 | JH_MS | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||
| Acute myeloid leukaemia with NPM1 mutation | Disease | PENDING | JH_MS | Acute Myeloid Leukemia (AML) with Mutated NPM1 | Xinjie Xu, PhD, FACMG | Complete | Add WHO reference | |||||||
| Acute myeloid leukaemia with CEBPA mutation | Disease | JH_MS | Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA | Paul Defazio, MSc, Monash Health | Complete | |||||||||
| Acute myeloid leukaemia, myelodysplasia-related | Disease | PENDING | JH_MS | Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes | Fei Yang, MD, FACMG Oregon Health & Science University |
Complete | ||||||||
| Acute myeloid leukaemia with other defined genetic alterations | Disease | JH_MS | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Acute myeloid leukaemia with minimal differentiation | Disease | JH_MS | Acute Myeloid Leukemia (AML) with Minimal Differentiation | Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine | Complete | |||||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Acute myeloid leukaemia without maturation | Disease | PENDING | JH_MS | Acute Myeloid Leukemia (AML) without Maturation | Jennelle C. Hodge, PhD, FACMG | Complete | ||||||||
| Acute myeloid leukaemia with maturation | Disease | PENDING | JH_MS | Acute Myeloid Leukemia (AML) with Maturation | Jennelle C. Hodge, PhD, FACMG | Complete | ||||||||
| Acute basophilic leukaemia | Disease | Ashwini Yenamandra PhD FACMG | 5/1/24 | JH_MS | Acute Basophilic Leukemia | Ashwini Yenamandra PhD FACMG | Complete | |||||||
| Acute myelomonocytic leukaemia | Disease | PENDING | JH_MS | Acute Myelomonocytic Leukemia | Fei Yang, MD, FACMG Oregon Health & Science University |
Complete | ||||||||
| Acute monocytic leukaemia | Disease | PENDING | JH_MS | Acute Monoblastic and Monocytic Leukemia | Fei Yang, MD, FACMG Oregon Health & Science University |
Complete | ||||||||
| Acute erythroid leukaemia | Disease | Ashwini Yenamandra PhD FACMG | 5/1/24 | JH_MS | Pure Erythroid Leukemia | Ashwini Yenamandra PhD FACMG | Complete | |||||||
| Acute megakaryoblastic leukaemia | Disease | PENDING | JH_MS | Acute Megakaryoblastic Leukemia (AMKL) | Fei Yang, MD, FACMG Oregon Health & Science University |
Complete | ||||||||
| Myeloid sarcoma | Disease | Yalda Naeini | 6/11/24 | JH_MS | Myeloid Sarcoma | Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine | Complete | |||||||
| RESOLVE 4th edition AML-Related NON-WHO entities content | Acute Myeloid Leukemia (AML) with Mutated FLT3 + Acute Myeloid Leukemia (AML) with NUP214-ABL1 + Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 | ISSUE- FIX
|
||||||||||||
| Myeloid neoplasm post cytotoxic therapy | Disease | (Rabail Aslam, MD)
Shashi Shetty, Ph.D. |
7/1/24 | JH_MS | Therapy-Related Myeloid Neoplasms | Shawn A. Silver, DO, Shashi Shetty, Ph.D. | Complete | Check reference format | ||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Myeloid neoplasms associated with germline predisposition | Disease | PENDING | JH_MS | Multiple pages including overview page (Myeloid Neoplasms with Germline Predisposition - Compendium of Cancer Genome Aberrations (ccga.io)) and 6 disease pages ( HAEM4:Acute Myeloid Leukaemia with Germline CEBPA Mutation, HAEM4:Myeloid Neoplasms with Germline DDX41 Mutation, HAEM4:Myeloid Neoplasms with Germline ETV6 Mutation, HAEM4:Myeloid Neoplasms with Germline GATA2 Mutation, HAEM4:Myeloid Neoplasms with Germline RUNX1 Mutation, HAEM4:Myeloid Neoplasms with Germline ANKRD26 Mutation) | See links from instructions on the 5th edition page | Complete | Most were re-reviewed by MS on 03/02/2021 | For page Acute Myeloid Leukaemia with Germline CEBPA Mutation - Note by MS of "Review completed, awaiting some clarification from JH - 07/04/2022" | ||||||
| Myeloid proliferations associated with Down syndrome | Disease | PENDING | JH_MS | MERGE 3 PAGES --> Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Myeloid Leukemia Associated with Down Syndrome | Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO | Complete (all three pages) | ||||||||
| Myeloid/lymphoid neoplasm with PDGFRA rearrangement | Disease | PENDING | FQR | Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement | Jay Alden, DO | Complete | ||||||||
| Myeloid/lymphoid neoplasm with PDGFRB rearrangement | Disease | PENDING | FQR | Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement | Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD | Complete | ||||||||
| Myeloid/lymphoid neoplasm with FGFR1 rearrangement | Disease | PENDING | FQR | Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement | Yanna Ding, MD PhD | Complete | ||||||||
| Myeloid/lymphoid neoplasm with JAK2 rearrangement | Disease | ISSUE- FIX
|
FQR | Myeloid/Lymphoid Neoplasms with PCM1-JAK2 + consider a non-WHO page Myeloid/Lymphoid Neoplasms with ETV6-JAK2 (Myeloid/Lymphoid Neoplasms with ETV6-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io)) + another non-WHO page Myeloid/Lymphoid Neoplasms with BCR-JAK2 (Myeloid/Lymphoid Neoplasms with BCR-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io) ) - both non-WHO pages are authored by trainee Lauren Crowson-Hindman and Daynna Wolff | Jessica Snider, M.D. and Daynna J. Wolff, PhD + non-WHO pages by trainee Lauren Crowson-Hindman and Daynna Wolff | Complete | ||||||||
| Myeloid/lymphoid neoplasm with FLT3 rearrangement | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion | Disease | Mayuri Shende (trainee) and Scott Turner (mentor) |
9/22/24 | Pending | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Mixed-phenotype acute leukaemia with BCR::ABL1 fusion | Disease | Tracy Tucker, PhD, FCCMG | 4/6/24 | Pending | JH_MS | Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 | Tracy Tucker, PhD, FCCMG | Complete | ||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Mixed-phenotype acute leukaemia with KMT2A rearrangement | Disease | Tracy Tucker, PhD, FCCMG | 4/6/24 | Pending | JH_MS | Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged | Tracy Tucker, PhD, FCCMG | Complete | ||||||
| Acute leukaemia of ambiguous lineage with other defined genetic alterations | Disease | JH_MS | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Mixed-phenotype acute leukaemia, B/myeloid | Disease | (Rabail Aslam, MD)
Shashi Shetty, Ph.D. |
7/1/24 | JH_MS | Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified | Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD | Complete | |||||||
| Mixed-phenotype acute leukaemia, T/myeloid | Disease | PENDING | JH_MS | Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified | Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | Complete | ||||||||
| Mixed-phenotype acute leukaemia, rare types | Disease | Daynna Wolff, PhD | 5/9/24 | JH_MS | Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types | Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | PENDING | |||||||
| Acute leukaemia of ambiguous lineage, NOS | Disease | JH_MS | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Acute undifferentiated leukaemia | Disease | (Rabail Aslam, MD)
Shashi Shetty, Ph.D. |
7/1/24 | JH_MS | Acute Undifferentiated Leukemia | Amelia Nakanishi, MD and Shashi Shetty, PhD | Complete | Check reference format | ||||||
CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm | Disease | Greg Corboy (GC) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Blastic plasmacytoid dendritic cell neoplasm | Disease | PENDING | GC | Blastic Plasmacytoid Dendritic Cell Neoplasm | Hao Liu, MD and Daynna J. Wolff, PhD | Complete | Previously within myeloid section under JH/MS editors | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Langerhans cell histiocytosis | Disease | PENDING | GC | Langerhans Cell Histiocytosis | Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | Complete | 5/19/2022 |
Date completed by author: 04/28/2022 | ||||||
| Langerhans cell sarcoma | Disease | PENDING | GC | Langerhans Cell Sarcoma | Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | Complete | 5/19/2022 |
Date completed by author: 04/28/2022 | ||||||
| Indeterminate dendritic cell tumour | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Interdigitating dendritic cell sarcoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Juvenile xanthogranuloma | Disease | Mayuri Shende (trainee) and Scott Turner (mentor) |
9/22/24 | Pending | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Erdheim-Chester disease | Disease | Mayuri Shende (trainee) and Scott Turner (mentor) |
9/22/24 | Pending | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Rosai-Dorfman Disease | Disease | Mayuri Shende (trainee) and Scott Turner (mentor) |
9/22/24 | Pending | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| ALK-positive histiocytosis | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Histiocytic sarcoma | Disease | PENDING | GC | Histiocytic Sarcoma | Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic | Complete | 10/01/2021 | Date completed by author: 10/01/2021 | ||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reactive B-cell rich lymphoid proliferations that can mimic lymphoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| IgG4-related disease | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Unicentric Castleman disease | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Idiopathic multicentric Castleman disease | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| KSHV/HHV8-associated multicentric Castleman disease | Disease | PENDING | GC | Multicentric Castleman Disease | Sudha Arumugam, MD | Complete | 01/24/2022 | Date completed by author: 01/24/2022 | ||||||
| B-lymphoblastic leukaemia/lymphoma | Disease | PENDING | Holli Drendel (HD) | B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified | Holli Drendel | PENDING | ||||||||
| B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy | Disease | PENDING | HD | B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy | Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG | PENDING | ||||||||
| B-lymphoblastic leukaemia/lymphoma with hypodiploidy | Disease | PENDING | HD | B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy | Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG | Complete | ||||||||
| B-lymphoblastic leukaemia/lymphoma with iAMP21 | Disease | Holli Drendel | ?Complete? Looks like tables need more editing. | HD | B-Lymphoblastic Leukemia/Lymphoma with iAMP21 [but was completed as a 5th edition page by Holli] | Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte | ?Complete | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion | Disease | PENDING | HD | B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 | Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG | PENDING | ||||||||
| B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features | Disease | PENDING | HD | B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like | Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine | Complete | ||||||||
| B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement | Disease | PENDING | HD | B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged | Yassmine Akkari Nicolas Millan | PENDING | ||||||||
| B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion | Disease | PENDING | HD | B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion | Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma | PENDING | ||||||||
| B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features | Disease | Lei Zhang and Michelle Fan (trainee) | 8/8/2024 | Pending | HD | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion | Disease | PENDING | HD | B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 | Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | PENDING | ||||||||
| B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion | Disease | PENDING | HD | B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3 | Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | PENDING | ||||||||
| B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion | Disease | Aiko Otsubo | 6/25/2024 | Pending | HD | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations | Disease | Lei Zhang and Michelle Fan (trainee) | 8/8/2024 | Pending | HD | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| B-lymphoblastic leukaemia/lymphoma, NOS | Disease | HD | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| RESOLVE 4th edition ALL-Related NON-WHO entities content | B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 + B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 + B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements + B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions + B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) + B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11) | ISSUE- FIX
|
ISSUE - FIX | |||||||||||
| Monoclonal B-cell lymphocytosis | Disease | PENDING; Shashirekha Shetty | Shivani Golem (SG) | Monoclonal B-cell Lymphocytosis | Tsigab Bahta Hagos (trainee) / Shashirekha Shetty | PENDING, 4/30/2024 | Assigned 12/19/2022 with completion date of 1/19/2023 | |||||||
| Chronic lymphocytic leukaemia/small lymphocytic lymphoma | Disease | Jaime Nagy, PhD, University of Iowa
Renee Eigsti, MD, Pathology Services of Kalamazoo Honey Reddi, PhD, Belay Diagnostics |
Complete | SG | Already converted to 5th edition | Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD | ||||||||
| Hairy cell leukaemia | Disease | Michael Lack, MD, KUMC (trainee)/Shivani Golem | 7/16/24 | PENDING | SG | Need new author to update latest content. Prior author cannot update the page. | Hairy Cell Leukemia | Snehal Patel, MD, PhD | Pending WHO 5th e. July 2024 | |||||
| Splenic marginal zone lymphoma | Disease | SG | Need new author to update latest content. Prior author cannot update the page. | Splenic Marginal Zone Lymphoma | Snehal Patel, MD, PhD | Complete | ||||||||
| Splenic diffuse red pulp small B-cell lymphoma | Disease | SG | Need new author to update latest content. Prior author cannot update the page. | Splenic Diffuse Red Pulp Small B-cell Lymphoma | Snehal Patel, MD, PhD | Complete | ||||||||
| Splenic B-cell lymphoma/leukaemia with prominent nucleoli | Disease | SG | Need new author to update latest content. Prior author cannot update the page. | Hairy Cell Leukemia Variant | Snehal Patel, MD, PhD | Complete | ||||||||
| Lymphoplasmacytic lymphoma | Disease | PENDING | SG | Email sent to request to update 2024 | (1) Lymphoplasmacytic Lymphoma + (2) Waldenstrom Macroglobulinemia | (1 and 2) Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) | Complete | 4/12/2023 by FQR | ||||||
| Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | Disease | PENDING | SG | Email sent to request to update 2024 | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) | Whayoung Lee, MD (trainee), Fabiola Quintero-Rivera, MD, FACMG*
Department of Pathology and Laboratory Medicine and *Pediatrics, School of Medicine, University of California Irvine (UCI) |
Complete | 4/12/23 by FQR | ||||||
| Primary cutaneous marginal zone lymphoma | Disease | SG | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Nodal marginal zone lymphoma | Disease | PENDING | SG | Nodal Marginal Zone Lymphoma | Andrew Ly, DO and Shivani Golem, PhD, FACMG | Complete | 5/28/2021 | |||||||
| Paediatric nodal marginal zone lymphoma | Disease | PENDING | SG | Need new author to update latest content. Prior authors cannot update the page. | Paediatric Nodal Marginal Zone Lymphoma | * Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD | Complete; Need new author to update latest content. Primary author cannot update the page. | 11/11/2020 | ||||||
| In situ follicular B-cell neoplasm | Disease | Rachel D. Burnside, PhD, MBA, FACMGG | 7/28/2023 | Pending | SG | In Situ Follicular Neoplasia | Rachel D. Burnside, PhD, MBA, FACMGG | Pending | ||||||
| Follicular lymphoma | Disease | Rachel D. Burnside, PhD, MBA, FACMGG | 7/28/2023 | Pending | SG | Author also needs to correlate with 4th edition disease "Testicular Follicular Lymphoma", which is no longer a separate entity | (1) Follicular Lymphoma + (2) Testicular Follicular Lymphoma | (1 and 2) Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida | Pending | |||||
| Paediatric-type follicular lymphoma | Disease | PENDING | SG | Need new author to update latest content. Prior authors cannot update the page. | Paediatric-Type Follicular Lymphoma | *Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG | Complete; Need new author to update latest content. Primary author cannot update the page. | 8/16/2020 | ||||||
| Duodenal-type follicular lymphoma | Disease | Rachel D. Burnside, PhD, MBA, FACMGG | 7/28/2023 | Pending | SG | Duodenal-Type Follicular Lymphoma | No prior content | |||||||
| Primary cutaneous follicle centre lymphoma | Disease | PENDING | SG | Primary Cutaneous Follicle Centre Lymphoma | Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG | Complete | 09/10/2022 | |||||||
| In situ mantle cell neoplasm | Disease | PENDING | SG | In Situ Mantle Cell Neoplasia | Rina Kansal, MD; Versiti Blood Center of Wisconsin | Complete | 7/26/2022 | |||||||
| Mantle cell lymphoma | Disease | PENDING | SG | Mantle Cell Lymphoma | Mahsa Khanlari, MD and Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | Pending | Target completion date 8/15/20 | |||||||
| Leukaemic non-nodal mantle cell lymphoma | Disease | SG | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Transformations of indolent B-cell lymphomas | Disease | SG | Include content on chronic myelomonocytic leukemia in transformation and refractory anaemia with excess blasts in transformation | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||||
| Diffuse large B-cell lymphoma, NOS | Disease | PENDING | GC | Diffuse Large B-cell Lymphoma, Not Otherwise Specified | Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | Pending | Requested to update 14022022 | |||||||
| T-cell/histiocyte-rich large B-cell lymphoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements | Disease | PENDING | GC | High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements | Kate Berry, MBBS, BBus (Hons), Pathology Queensland | Complete | 24/02/2022 | |||||||
| ALK-positive large B-cell lymphoma | Disease | PENDING | GC | ALK-Positive Large B-cell Lymphoma | Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine) | Pending | Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note). 2021 template added. FQR emailed Manando on 4/12/23 | |||||||
| Large B-cell lymphoma with IRF4 rearrangement | Disease | PENDING | GC | Large B-cell Lymphoma with IRF4 Rearrangement | Afia Hasnain, MBBS, PhD | Complete | 5/26/2021 | |||||||
| High grade B-cell lymphoma with 11q aberrations | Disease | PENDING | GC | Burkitt-Like Lymphoma with 11q Aberration | Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | Comlete | 27/01/2022 | |||||||
| Lymphomatoid granulomatosis | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| EBV-positive diffuse large B-cell lymphoma | Disease | Fnu Monika (trainee) + Andrew Siref as mentor | 3/22/24 | Pending | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Diffuse large B-cell lymphoma associated with chronic inflammation | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Fibrin-associated large B-cell lymphoma | Disease | PENDING | GC | Note: previously a subset DLBCL assoc with chronic inflam | Originally called Fibrin-Associated Diffuse Large B-cell Lymphoma; NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||
| Fluid overload-associated large B-cell lymphoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Plasmablastic lymphoma | Disease | PENDING | GC | Plasmablastic Lymphoma | Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | Complete | 28/03/2022 | |||||||
| Primary large B-cell lymphoma of immune-privileged sites | Disease | PENDING | GC | (1) Diffuse Large B-cell Lymphoma, Not Otherwise Specified + (2) Primary Diffuse Large B-cell Lymphoma of the CNS | (1) Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center + (2) Laveniya Satgunaseelan, FRCPA, Department of Neuropathology, Royal Prince Alfred Hospital | (1) Pending + (2) Complete | (1) Not ready + (2) 03/28/22 | For "Diffuse Large B-cell Lymphoma, Not Otherwise Specified" page from Ash, Greg requested to update 14022022 | ||||||
| Primary cutaneous diffuse large B-cell lymphoma, leg type | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Intravascular large B-cell lymphoma | Disease | PENDING | GC | Intravascular Large B-cell Lymphoma | Kate Berry, MBBS, BBus (Hons), Pathology Queensland, Greg Corboy | Complete | 9/1/22 | Emailed 28/3/2022 for progress update | ||||||
| Primary mediastinal large B-cell lymphoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Mediastinal grey zone lymphoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| High-grade B-cell lymphoma, NOS | Disease | PENDING | GC | High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS) | Aiko Otsubo, PhD, Indiana University, Holli Drendel | Complete | 16/11/2021 | |||||||
| Burkitt lymphoma | Disease | PENDING | GC | Burkitt Lymphoma | Becky Leung, MBBS (Hons), BSc, Pathology Queensland | Complete | 28/06/2021 | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Primary effusion lymphoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| KSHV/HHV8-positive diffuse large B-cell lymphoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| KSHV/HHV8-positive germinotropic lymphoproliferative disorder | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Hyperplasias arising in immune deficiency/dysregulation | Disease | FIX ISSUE! (on 5th edition page instructions say "encompassing non-destructive post-transplant lymphoproliferative disorders, among others"). "Non-Destructive Post-Transplant Lymphoproliferative Disorders" was a HAME4 page but no content. What are "among others" from HAEM4 to see if we need to pull prior content into 5th edition page. | GC | |||||||||||
| Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation | Disease | FIX ISSUE! (on 5th edition page instructions say "This page was converted to the new template on 2023-12-07. The original page can be found at HAEM4:Polymorphic Post-Transplant Lymphoproliferative Disorders.
Note: encompassing polymorphic PTLD, other iatrogenic immunodef-assoc lympho disorders, among others)" |
GC | Polymorphic Post-Transplant Lymphoproliferative Disorders | Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI) | Completed | 26/4/2022 | |||||||
| EBV-positive mucocutaneous ulcer | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Lymphomas arising in immune deficiency / dysregulation | Disease | FIX ISSUE! (on 5th edition page instructions say "encompassing monomorphic PTLD, classic HL PTLD, lymphomas assoc with HIV infection, among others" | GC | |||||||||||
| Inborn error of immunity-associated lymphoid proliferations and lymphomas | Disease | FIX ISSUE! (on 5th edition page instructions say "Editor said this overview page is a match. [Immunodeficiency-Associated Lymphoproliferative Disorders] [Lymphoproliferative diseases associated with primary immune disorders]") - last link name above is not a known page in haem4 or haem5. | GC | |||||||||||
| Classic Hodgkin lymphoma | Disease | PENDING | GC | Note: author needs to merge Nodular Sclerosis Classic Hodgkin Lymphoma, Lymphocyte-Rich Classic Hodgkin Lymphoma, Mixed Cellularity Classic Hodgkin Lymphoma, Lymphocyte-Depleted Classic Hodgkin Lymphoma | (1) Lymphocyte-Rich Classic Hodgkin Lymphoma + (2) Nodular Sclerosis Classic Hodgkin Lymphoma + (3) Mixed Cellularity Classic Hodgkin Lymphoma + (4) Lymphocyte-Depleted Classic Hodgkin Lymphoma | (1) Patricia V. Hernandez, M.D., Washington University School of Medicine and Holli Drendel + (2) Xiaolin Hu, PhD, Sema4 OpCo Inc. + (3 and 4) Patricia V. Hernandez | Pending + Completed (03/21/22) | Not completed for checking (1, 3 and 4) + 03/21/22 (2) | ||||||
| Nodular lymphocyte predominant Hodgkin lymphoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Cold agglutinin disease | Disease | SG | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| IgM monoclonal gammopathy of undetermined significance | Disease | SG | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Non-IgM monoclonal gammopathy of undetermined significance | Disease | SG | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Monoclonal gammopathy of renal significance | Disease | SG | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Immunoglobulin-related (AL) amyloidosis | Disease | PENDING | SG | Primary Amyloidosis | Heather E. Williams, PhD, MS, PgD, ErCLG | ?PENDING |
||||||||
| Monoclonal immunoglobulin deposition disease | Disease | PENDING | SG | Light Chain and Heavy Chain Deposition Disease | Chen Yang, MD, PhD, University of Michigan | Complete | 10/15/2022 | |||||||
| Mu heavy chain disease | Disease | SG | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Gamma heavy chain disease | Disease | PENDING | SG | Gamma Heavy Chain Disease | Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA | Complete | 5/26/2021 | |||||||
| Alpha heavy chain disease | Disease | SG | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Plasmacytoma | Disease | PENDING | SG | author needs to include Solitary plasmacytoma of bone, Extraosseous plasmacytoma (extramedullary) (v4 page did not have content on ccga) | NEW (No Prior) - no content on version 4 page "Plasmacytoma' originally assigned to Zhenya Tang | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Plasma cell myeloma / multiple myeloma | Disease | PENDING | SG | Note: author needs to include Plasma_Cell_Myeloma_Variants content in this page | (1) Plasma Cell Myeloma + (2) Plasma Cell Myeloma Variants | (1) Huan Mo, MD, MS and Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas + (2) Fariborz Rashid-Kolvear, PhD, FACMG, FCCMG | Pending | |||||||
| Plasma cell neoplasms with associated paraneoplastic syndrome | Disease | PENDING | SG | Note: author needs to include POEMS, TEMPI, and look for AESOP content | (1) POEMS Syndrome + (2) TEMPI Syndrome | (1 and 2) Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD | ?PENDING | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parenthesis) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition) (Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition) (Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Kikuchi-Fujimoto disease | Disease | Sumi Kitahara (SK) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Autoimmune lymphoproliferative syndrome | Disease | Aviv Oren, MD (trainee), Karin Miller, MD | 3/25/2024 | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||
| Indolent T-lymphoblastic proliferation | Disease | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| T-lymphoblastic leukaemia / lymphoma, NOS | Disease | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Early T-precursor lymphoblastic leukaemia / lymphoma | Disease | Fei Yang, MD | Pending | SK | Early T-Cell Precursor Lymphoblastic Leukemia | Fei Yang, MD, FACMG, Kaiser Permanente Northwest | Pending | |||||||
| T-prolymphocytic leukaemia | Disease | Parastou Tizro, MD (trainee); Celeste Eno, PhD | 3/17/2024 | Complete | 6/24/2024 | SK | 7/1/2024 | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| T-large granular lymphocytic leukaemia | Disease | Nicolas LaScala (trainee); Michelle Don, MD, MS | 3/17/2024 (trainee name added on 9/9/24 by JH) | 6/30/24 | Pending | SK | T-cell Large Granular Lymphocytic Leukemia | Michelle Don, MD, MS | Pending | |||||
| NK-large granular lymphocytic leukaemia | Disease | Hailee St. Louis (trainee);
Michelle Don, MD, MS |
3/17/2024 | 6/30/24 | Pending | SK | Chronic Lymphoproliferative Disorder of NK Cells | Michelle Don, MD | Pending | |||||
| Adult T-cell leukaemia/lymphoma | Disease | SK | Adult T-cell Leukemia/Lymphoma | Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center | ?Pending | |||||||||
| Sezary syndrome | Disease | Daynna J. Wolff, PhD | 3/22/2024 | SK | Sézary Syndrome | Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina | Pending | |||||||
| Aggressive NK-cell leukaemia | Disease | Rabail Aslam, MD (fellow); Shashirekha Shetty, PhD | 7/1/2024 | 8/31/2024 | Pending | SK | Aggressive NK-cell Leukemia | Shanelle De Lancy, MD, Shashirekha Shetty, PhD | ?Pending | |||||
| Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder | Disease | Amanda Xu, MD/MSc, Teodora Popa (resident) | 3/19/2024 | Pending | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder | Disease | Ahmed Eladely (trainee),
Andrew Siref, MD |
4/12/2024 | Pending | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Mycosis fungoides | Disease | Daynna J. Wolff, PhD | 3/22/2024 | SK | Mycosis Fungoides | Jane Scribner, MD and Daynna J. Wolff, PhD | Pending | |||||||
| Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis | Disease | Rabail Aslam, MD (fellow); Shashirekha Shetty, PhD | 7/1/2024 | 8/31/224 | Pending | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||
| Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma | Disease | Rabail Aslam, MD (fellow); Shashirekha Shetty, PhD | 7/1/2024 | 8/31/2024 | Pending | SK | Primary Cutaneous Anaplastic Large Cell Lymphoma | Theresa Spivey, MD, Shashirekha Shetty, PhD | Pending | |||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Subcutaneous panniculitis-like T-cell lymphoma | Disease | Raniah Alamri (Hemepath trainee) | 3/19/2024 | Pending | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Primary cutaneous gamma/delta T-cell lymphoma | Disease | Mahzad Azimpouran (trainee); Sumire Kitahara, MD | 6/30/2024 | Pending | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma | Disease | Ahmed Eladely (trainee),
Andrew Siref, MD |
4/12/2024 | Pending | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Primary cutaneous peripheral T-cell lymphoma, NOS | Disease | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Indolent T-cell lymphoma of the gastrointestinal tract | Disease | SK | Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract | Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | Pending | |||||||||
| Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract | Disease | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Enteropathy-associated T-cell lymphoma | Disease | Fnu Monika, MBBS (trainee),
Andrew Siref, MD |
3/20/2024 | Pending | SK | Enteropathy-Associated T-cell Lymphoma | *Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD | Complete | 1/21/2021 | |||||
| Monomorphic epitheliotropic intestinal T-cell lymphoma | Disease | Fnu Monika, MBBS (trainee),
Andrew Siref, MD |
3/20/2024 | Pending | SK | Monomorphic Epitheliotropic Intestinal T-cell Lymphoma | Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | Pending | ||||||
| Intestinal T-cell lymphoma, NOS | Disease | SK | Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) | Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA) | Complete | 9/26/2022 | ||||||||
| Hepatosplenic T-cell lymphoma | Disease | Forough Sargolzaeiaval (trainee);
Michelle Don, MD, MS |
3/19/2024 | 6/30/24 | Complete | 5/13/24 | SK | 10/18/24 | Hepatosplenic T-cell Lymphoma | Michelle Don, MD, MS | Complete | 1/21/2021 | ||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| ALK-positive anaplastic large cell lymphoma | Disease | Miguel Gonzalez Mancera, MD (trainee)
Sumire Kitahara, MD |
6/6/24 | Pending | SK | Anaplastic Large Cell Lymphoma, ALK-Positive | Miguel Gonzalez Mancera, MD
Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA |
Complete | 09/23/2022 | |||||
| ALK-negative anaplastic large cell lymphoma | Disease | Miguel Gonzalez Mancera, MD (trainee)
Sumire Kitahara, MD |
6/6/24 | Pending | SK | Anaplastic Large Cell Lymphoma, ALK-Negative | Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA | Complete | 09/23/2022 | |||||
| Breast implant-associated anaplastic large cell lymphoma | Disease | Lynne Abruzzo, MD, PhD | 4/1/2024 | Pending | SK | Breast Implant-Associated Anaplastic Large Cell Lymphoma | Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center | Pending | ||||||
| Nodal TFH cell lymphoma, angioimmunoblastic-type | Disease | Rachel Burnside, PhD | 7/28/2023 | Pending | SK | prior authors not available | Angioimmunoblastic T-cell Lymphoma | Sara Akhavanfard, M.D., Ph.D. and Ruthann Pfau, Ph.D., FACMG | Pending | |||||
| Nodal TFH cell lymphoma, follicular-type | Disease | Rachel Burnside, PhD | 7/28/2023 | Pending | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Nodal TFH cell lymphoma, NOS | Disease | SK | Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype | Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD | Pending | |||||||||
| Peripheral T-cell lymphoma, NOS | Disease | Bo Hong, MD | 6/25/2023 | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||
| EBV-positive nodal T- and NK-cell lymphoma | Disease | Fnu Monika, MBBS (trainee), Andrew Siref, MD | 3/22/2024 | Pending | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Extranodal NK/T-cell lymphoma | Disease | Amanda Xu, MD/MSc, Teodora Popa (resident) | 3/19/2024 | Pending | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||
| Severe mosquito bite allergy | Disease | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Hydroa vacciniforme lymphoproliferative disorder | Disease | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Systemic chronic active EBV disease | Disease | Karin Miller, MD | 3/25/2024 | SK | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||
| Systemic EBV-positive T-cell lymphoma of childhood | Disease | Karin Miller, MD | 3/25/2024 | SK | prior authors not available | Systemic EBV-Positive T-cell Lymphoma of Childhood | Lisa A. Lansdon, PhD and Linda D. Cooley, MD, MBA | Complete | 11/21/2021 | |||||
CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Follicular dendritic cell sarcoma | Disease | PENDING | GC | Follicular Dendritic Cell Sarcoma | Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG | ?Pending | ||||||||
| EBV-positive inflammatory follicular dendritic cell sarcoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Fibroblastic reticular cell tumour | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Intranodal palisaded myofibroblastoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
| Littoral cell angioma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Splenic hamartoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Sclerosing angiomatoid nodular transformation (SANT) of spleen | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
CHAPTER 7 (GENETIC TUMOUR SYNDROMES) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fanconi anaemia | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) |
| Bloom syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) |
| Ataxia-telangiectasia syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) |
| RASopathies | Disease | NA | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) |